gabexate has been researched along with Glomerulonephritis, IGA in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Glomerulonephritis, IGA: A chronic form of glomerulonephritis characterized by deposits of predominantly IMMUNOGLOBULIN A in the mesangial area (GLOMERULAR MESANGIUM). Deposits of COMPLEMENT C3 and IMMUNOGLOBULIN G are also often found. Clinical features may progress from asymptomatic HEMATURIA to END-STAGE KIDNEY DISEASE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsubara, M | 1 |
| Taguma, Y | 1 |
| Saito, T | 1 |
| Yoshinaga, K | 1 |
1 other study available for gabexate and Glomerulonephritis, IGA
| Article | Year |
|---|---|
Effect of camostat mesilate on persistent proteinuria of IgA nephropathy.
Topics: Administration, Oral; Adult; Esters; Female; Gabexate; Glomerulonephritis, IGA; Guanidines; Humans; | 1992 |